As communities continue to be impacted by COVID-19, we are a reliable source for people in search of answers. We are working closely with our infectious disease experts, other health care entities, and federal, state, and local agencies to ensure our information is accurate and up to date.
A clinical trial investigating whether high-dose vitamin D3 supplements combined with a multivitamin could effectively prevent cluster headaches is now recruiting patients at The University of Texas Health Science Center at Houston (UTHealth Houston).
A recent study revealed that endovascular repair of complex aortic aneurysms using fenestrated and branched endografts provides a safe and effective alternative to open surgical repair, with the lowest ever reported mortality rate in this patient population, according to researchers at The University of Texas Health Science Center at Houston (UTHealth Houston) and Memorial Hermann Heart and Vascular Institute Aortic Center.
Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston (UTHealth).
Telemedicine appointments combined with in-person visits significantly reduced the risk of further illness for children with medically complex cases, according to results of a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth).
.jpg)
Pregnant women hospitalized with COVID-19 had improved recovery outcomes after delivering their babies early, according to new research from The University of Texas Health Science Center at Houston (UTHealth).
A five-year, nearly $6 million grant from the National Institute on Aging will allow investigators with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics to use artificial intelligence (AI) to advance Alzheimer’s disease research.
Women are less likely than men to receive timely care for strokes caused by blockages in large vessels, known as emergent large vessel occlusion (ELVO), according to researchers with The University of Texas Health Science Center at Houston (UTHealth).
With overdose rates involving cocaine soaring nearly 27% in 2020, researchers at The University of Texas Health Science Center at Houston (UTHealth) hope that a clinical trial combining a medication approved for the treatment of Type 2 diabetes with cognitive behavioral therapy (CBT) can help prevent relapse in cocaine use disorder patients.
Projects of the Center for Clinical and Translational Sciences include several initiatives to address testing disparities in vulnerable and underserved populations across the state, including in the Houston metro area, in South Texas, and in East Texas and West Texas, which have higher rates of uninsured and African American populations.
